I am trying to come up with a well-reasoned dosage of ALCAR adjusted to my age (40). This is from the point of view of someone unwilling to risk co-supplementation with ALA. In the absence of dose-ranging studies on healthy humans, I guess we mainly have the Ames rat studies to use a a basis. Lessons from the Ames studies are that too high a dosage not only causes oxidative damage but can be less effective than lower dosages that avoid the oxidative damage side effect.
Specifically, in old rats:
- 1.5% in drinking water (equivalent to about 12g daily in 70 kg humans) is too much. It is the least effective of the three dosages tested and increases markers of oxidative damage.
- 0.5% in drinking water (equivalent to about 4g daily in 70 kg humans) is optimal among the three dosages tested. It is more effective than the higher dosage in ambulatory activity and mitochondrial rehabilitation and does not increase markers of oxidative damage.
- 0.15% in drinking water (equivalent to about 1.2g daily in 70 kg humans), while less effective than the 0.5% dosage, is still significantly more effective than the 1.5% dosage with respect to ambulatory activity.
Delaying Brain Mitochondrial Decay and Aging with Mitochondrial Antioxidants and Metabolites
JIANKANG LIU, HANI ATAMNA, HIROHIKO KURATSUNE, AND BRUCE N. AMES
However, for younger individuals, it seems probable that the 1g to 4g range may be too high, be less effective than lower dosages and may in fact cause oxidative harm. For example, from the rat studies, for the same 1.5% dosage of ALCAR, younger rats have a larger absolute decline in cellular ascorbate levels. See for example one of the slides in http://mcb.berkeley......s Lecture.pdf. So, it seems likely that the above range must be adjusted downward depending on age.
Now if aging were linear, this adjustment would presumably be straightforward, from a presumably optimal but potentialy risky (due to lack of human data) dosage of 0g at age 20 to 4g at age 80, or a conservative, less risky dose of 0g at 20 to 1g at 80. This would give an optimal dosage of 1.3 g at age 40, or a more prudent conservative dose of 300mg at age 40.
The problem is, however, that aging is probably not linear. If the falloff is more rapid later than earlier, which seems likely, the dosages at age forty should be less than the linear interpolation would suggest. Maybe much less, depending on the shape of the graph.
Any suggestions?
Edited by andre, 30 November 2008 - 04:07 PM.